Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 10-Q, Date: 2014-05-15, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: TPI/20140515/10-Q/1/000.htm SEC Original: f10q0314_tianyinpharma.htm
FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2014 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +86 028 8551 6696 (Address, including

---

---

Webplus: TPI/20140515/10-Q/2_EX-31.1/000.htm SEC Original: f10q0314ex31i_tianyin.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make

---

---

Webplus: TPI/20140515/10-Q/3_EX-31.2/000.htm SEC Original: f10q0314ex31ii_tianyin.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to

---

---

Webplus: TPI/20140515/10-Q/4_EX-32.1/000.htm SEC Original: f10q0314ex32i_tianyin.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0314ex32i_tianyin.htm CERTIFICATION

---

---

Webplus: TPI/20140515/10-Q/5_EX-32.2/000.htm SEC Original: f10q0314ex32ii_tianyin.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0314ex32ii_tianyin.htm CERTIFICATION

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 10-Q, Date: 2014-05-15, XBRL Interactive FinancialsCIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041